| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/02/2001 | EP1094843A1 Targeted site specific drug delivery compositions and method of use |
| 05/02/2001 | EP1094840A1 Use of texaphyrins in macrophage-mediated disease |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | EP1094820A2 Use of bisphosphonates in the treatment of vascular restenosis |
| 05/02/2001 | EP1094816A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/02/2001 | EP1094810A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 05/02/2001 | EP1094806A2 Vasculoprotector |
| 05/02/2001 | EP1094805A1 Substituted oxygen alicyclic compounds, including methods for synthesis thereof |
| 05/02/2001 | EP1094801A2 Poly(diallylamine)-based bile acid sequestrants |
| 05/02/2001 | EP1094797A1 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
| 05/02/2001 | EP1094793A1 Composition containing glycerol trinitrate, method for producing said composition and use of the same |
| 05/02/2001 | EP1094712A1 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | EP0769947B1 Indolinone compounds for the treatment of disease |
| 05/02/2001 | EP0743853B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 05/02/2001 | CN1293712A Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
| 05/02/2001 | CN1293673A 1-(3-heteroarylpropyl-or-prop-2-enyl)-4-benzylpiperidines used as NMDA receptor antagonists |
| 05/02/2001 | CN1293666A Benzenesulfonamide-derivatives and their use as medicaments |
| 05/02/2001 | CN1293665A New compounds and their use as positive AMPA receptor modulators |
| 05/02/2001 | CN1293662A Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 05/02/2001 | CN1293655A Bicyclo [2.2.1] heptanes and related compounds |
| 05/02/2001 | CN1293575A Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as estrofen-like organ-selective medicament without uteroetropic effects |
| 05/02/2001 | CN1293574A Materials for preventing arteriosclerosis, Immunopotentiating meterials, vertegrates fed with these materials and eggs thereof |
| 05/02/2001 | CN1293195A New polycyclicazaindole compound, its preparation method are medicine composition containing same |
| 05/02/2001 | CN1293049A 'Shexingkeyu' capsule for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 05/02/2001 | CN1065244C Tricyclic benzazepine vasopressin antagonists |
| 05/02/2001 | CN1065140C synergistic therapeutic composition and methods |
| 05/01/2001 | US6225494 Trisubstituted phenyl derivatives having retinoid agonist or inverse agonist type biological activity |
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225354 Subjecting unsaponified beeswax to liquid extraction with liquid organic extractant in which primary aliphatic alcohols are soluble; recovering alcohol mixture and isolating alcohols |
| 05/01/2001 | US6225339 Terpenoid lactone compounds and their production process |
| 05/01/2001 | US6225335 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease |
| 05/01/2001 | US6225331 For therapy and prophylaxis nasal congestion, otitis media, and sinusitis, treating cough, chronic obstructive pulmonary disease (copd) and/or asthma, benign prostatic hypertrophy, cardiovascular disorders, glaucoma, hyperemia, conjunctivitis |
| 05/01/2001 | US6225328 Adamantyl-substituted retinoids and pharmaceutical/cosmetic compositions comprised thereof |
| 05/01/2001 | US6225320 Treatment of pain, inflammation, migraine, emesis and posttherpetic neuralgia |
| 05/01/2001 | US6225302 Amidino protease inhibitors |
| 05/01/2001 | US6225291 Rod opsin mRNA-specific ribozyme compositions and methods for the treatment of retinal diseases |
| 05/01/2001 | US6225290 Provides advantages:short term or long term cures and/or treatment, avoids invasive procedures, oral administration, naked dna is used rather than viral vectors, side-effects of long term gene administration can be avoided |
| 05/01/2001 | US6225288 Implicated in modulating apoptosis; treatment of:cardiac and cerebral ischemia/reperfusion injury, spinal cord injury and organ damage during transplantation, chronic neurodegenerative diseases, immunodeficiency, diabetes, alopecia, aging |
| 05/01/2001 | US6225284 Somatostatin peptides |
| 05/01/2001 | US6225102 Amino acid sequence of guanosine triphosphatase from streptococcus; diagnosis; prophylaxis; drug screening; bactericides; bacteriostats |
| 05/01/2001 | US6225084 Nucleotide and amion acid sequence of genes that are up-regulated in endothelial cells subjected to shear stress; atherosclerosis, antiischemic agents; hypotensive agents; restenosis; antiinflammatory agents for arteries |
| 05/01/2001 | CA2016664C Indole derivative and method of production thereof |
| 05/01/2001 | CA2001265C Analogs of peptidase substrates |
| 04/29/2001 | CA2324640A1 Method for preparing sodium-hydrogen exchanger type 1 inhibitor |
| 04/26/2001 | WO2001029219A1 Human cub-domain-containing protein and gene encoding the same |
| 04/26/2001 | WO2001029206A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/26/2001 | WO2001029199A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 04/26/2001 | WO2001029129A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/26/2001 | WO2001029082A1 A DNA MOLECULE ENCODING A VARIANT α2B-ADRENOCEPTOR PROTEIN, AND USES THEREOF |
| 04/26/2001 | WO2001029055A2 Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
| 04/26/2001 | WO2001029049A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 04/26/2001 | WO2001029042A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029041A1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029039A1 Synthesis and methods of use of 9-substituted guanine derivatives |
| 04/26/2001 | WO2001029036A2 Allosteric sites on muscarinic receptors |
| 04/26/2001 | WO2001029028A1 9- (piperazinylalkyl) carbazoles as bax-modulators |
| 04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 04/26/2001 | WO2001029025A2 Tyrosine kinase inhibitors |
| 04/26/2001 | WO2001029023A1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 04/26/2001 | WO2001029022A1 Benzopyran derivatives |
| 04/26/2001 | WO2001029018A2 Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use |
| 04/26/2001 | WO2001029015A2 Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists |
| 04/26/2001 | WO2001029012A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 04/26/2001 | WO2001029011A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 04/26/2001 | WO2001029009A1 4,5-disubstituted-2-aminopyrimidines |
| 04/26/2001 | WO2001029007A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 04/26/2001 | WO2001029000A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 04/26/2001 | WO2001028993A2 Tyrosine kinase inhibitors |
| 04/26/2001 | WO2001028992A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/26/2001 | WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/26/2001 | WO2001028978A1 Bicyclic amino acids as pharmaceutical agents |
| 04/26/2001 | WO2001028588A1 Cannabinoids as vasodilators and cardioprotectors against ischemia |
| 04/26/2001 | WO2001028580A2 Modulation of angiogenesis |
| 04/26/2001 | WO2001028560A1 A new use of levosimendan |
| 04/26/2001 | WO2001028557A1 Cannabimimetic indole derivatives |
| 04/26/2001 | WO2001028550A1 Topical anesthetics useful for treating cancer, autoimmune diseases and ischemia |
| 04/26/2001 | WO2001028549A1 Anti-ischemic compounds |
| 04/26/2001 | WO2001028548A1 Treatment of heart disease with cox-2 inhibitors |
| 04/26/2001 | WO2001028523A1 Powder pharmaceutical formulations |
| 04/26/2001 | WO2001028498A2 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 04/26/2001 | WO2001028497A2 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 04/26/2001 | WO2001028492A2 Polyanhydrides with biologically active degradation products |
| 04/26/2001 | WO2001028365A1 Dietary supplement |
| 04/26/2001 | WO2001028363A1 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves |
| 04/26/2001 | WO2001003645A3 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 04/26/2001 | WO2000064486A3 Enzymatically activated polymeric drug conjugates |
| 04/26/2001 | WO2000063369A3 Gene therapy |
| 04/26/2001 | WO2000061609B1 Prodrugs of thrombin inhibitors |
| 04/26/2001 | WO2000056293A3 Medicaments containing doxazosin-mesylate of crystalline modification d |
| 04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | WO2000044357A3 Agent for preventing in-stent restenoses and post-operative inflammations |
| 04/26/2001 | WO2000008020A8 Tricyclic carboxamides |
| 04/26/2001 | US20010000513 Treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation |
| 04/26/2001 | DE19951022A1 New pyridoindolylmethyl-phenylacetic acid amide derivatives useful in lowering serum cholesterol levels in treatment of e.g. atherosclerosis, coronary heart disease, apoplexy and thromboses |
| 04/26/2001 | DE19950898A1 New heteroaryl substituted fluoroalkyl-benzoylguanidine derivatives useful for treatment of e.g. ischemias, cardiac infarction, angina, shock, atherosclerosis, cancer and metabolic disorders |
| 04/26/2001 | DE19950647A1 Benzopyranoimidazolone and benzothiopyranoimidazolone derivatives as phosphodiesterase-VII inhibitors useful for treatment of e.g. asthma, psoriasis, osteoporosis, cachexia, sepsis, tumors and AIDS |